This study, therefore, was designed to determine the serum PTX3 levels in patients with various cross-sectional diseases including chronic hepatitis, cirrhosis and HCC during chronic HBV infection and to assess the potential diagnostic value in distinguishing HCC, including AFP-negative and early HCC, from other disease conditions in chronic HBV infection. The gene discussed is AFP; the disease is chronic hepatitis.